Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
148.36
+2.86 (1.97%)
At close: May 6, 2026, 4:00 PM EDT
147.84
-0.52 (-0.35%)
After-hours: May 6, 2026, 7:59 PM EDT

Novartis AG Revenue

Novartis AG had revenue of $13.52B in the quarter ending March 31, 2026, a decrease of -0.70%. This brings the company's revenue in the last twelve months to $56.58B, up 6.31% year-over-year. In the year 2025, Novartis AG had annual revenue of $56.67B with 9.57% growth.

Revenue (ttm)
$56.58B
Revenue Growth
+6.31%
P/S Ratio
5.01
Revenue / Employee
$751,697
Employees
75,267
Market Cap
283.17B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202556.67B4.95B9.57%
Dec 31, 202451.72B5.06B10.85%
Dec 31, 202346.66B3.20B7.36%
Dec 31, 202243.46B-513.00M-1.17%
Dec 31, 202143.97B-5.92B-11.87%
Dec 31, 202049.90B1.22B2.51%
Dec 31, 201948.68B2.58B5.59%
Dec 31, 201846.10B2.70B6.21%
Dec 31, 201743.40B-6.03B-12.20%
Dec 31, 201649.44B-951.00M-1.89%
Dec 31, 201550.39B-3.25B-6.05%
Dec 31, 201453.63B918.00M1.74%
Dec 31, 201352.72B745.00M1.43%
Dec 31, 201251.97B-7.40B-12.47%
Dec 31, 201159.38B7.81B15.15%
Dec 31, 201051.56B6.46B14.32%
Dec 31, 200945.10B2.52B5.92%
Dec 31, 200842.58B3.64B9.34%
Dec 31, 200738.95B3.84B10.94%
Dec 31, 200635.11B5.35B17.99%
Dec 31, 200529.75B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Johnson & Johnson96.36B
Merck & Co.65.77B
Pfizer63.32B
AbbVie62.82B
AstraZeneca60.44B
Sanofi54.60B
Novo Nordisk48.59B
Bristol-Myers Squibb Company48.48B
Revenue Rankings